Probably Genetic Wins Up to $10M ARPA-H Contract
Probably Genetic has been awarded up to $10 million by the Advanced Research Projects Agency for Health (ARPA-H) to expand its AI platform for diagnosing rare genetic diseases, the San Francisco company announced on August 31, 2026. The award was made under ARPA-H's Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program, a federal effort to shorten the years-long search many patients face before receiving an accurate diagnosis. ARPA-H is an agency within the U.S. Department of… [...]
Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Equal Parts Launches with $10M to Revolutionize Independent Insurance Through AI and Human Connection
In a bold move to reimagine the future of independent insurance, Equal Parts has officially launched with $10 million in acquisition capital, backed by Equal Ventures and Max Ventures. The Austin-bas [...]
Lumai Raises $10M+ to Revolutionize AI Compute with Optical Processing
In a major leap forward for the future of artificial intelligence infrastructure, Lumai, the Oxford-born startup pioneering 3D optical computing, has raised more than $10 million in a fresh funding ro [...]
ChatGPT helped identify a genetic MTHFR mutation after a decade of missed diagnoses
People are reporting cases where ChatGPT has cracked medical mysteries that even specialized teams couldn't solve. The AI analyzes symptoms, lab results, and imaging data, then suggests hypothese [...]
Empirical Ventures secures £10M from the British Business Bank to back UK ‘venture scientists
Empirical Ventures, which backs what it calls “venture scientists”, PhDs building deeptech companies across energy, materials, and life sciences, has received a fresh £10M commitment via the BBB [...]
Helical closes $10M seed to turn bio foundation models into systems
The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by redalpine, with the CE [...]
Modus Raises $10M Seed Led by Insight Partners as Enterprise AI Creates Demand for a New Context Layer
The enterprise AI market is moving into a new phase. As companies shift from experimenting with individual AI applications to deploying agents across business operations, the challenge is increasingly [...]
23andMe founder Anne Wojcicki will regain control of embattled DNA company after all
In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called Regener [...]